These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36641136)

  • 1. Long noncoding RNA FGD5-AS1 alleviates childhood IgA nephropathy by targeting PTEN-mediated JNK/c-Jun signaling pathway via miR-196b-5p.
    Sun Q; Liu X; Wang M; Fan J; Zeng H
    Exp Cell Res; 2023 Mar; 424(1):113481. PubMed ID: 36641136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LncRNA FGD5-AS1/miR-497-5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin-resistance in laryngeal squamous cell carcinoma.
    Song K; Yu P; Zhang C; Yuan Z; Zhang H
    Mol Carcinog; 2021 Jul; 60(7):469-480. PubMed ID: 34003510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
    Cui F; Luo P; Bai Y; Meng J
    Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z; Kun W; Xiaochun S; Lingling T
    Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis.
    Fu J; Cai H; Wu Y; Fang S; Wang D
    Gene; 2020 Sep; 755():144886. PubMed ID: 32534055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR‑214-3p attenuates mesangial hypercellularity by targeting PTEN‑mediated JNK/c-Jun signaling in IgA nephropathy.
    Li Y; Xia M; Peng L; Liu H; Chen G; Wang C; Yuan D; Liu Y; Liu H
    Int J Biol Sci; 2021; 17(13):3343-3355. PubMed ID: 34512151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC).
    Zhang L; Cai X; Dai Y; Chen Y; Yu J; Zhou Y
    Biomed Res Int; 2022; 2022():1133332. PubMed ID: 35845947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Long Noncoding RNA FGD5-AS1 Ameliorates Myocardial Ischemia/Reperfusion Injury via MicroRNA-106a-5p and MicroRNA-106b-5p.
    Hao L; Wang J; Bi SJ; Cheng C
    J Cardiovasc Pharmacol; 2021 Jul; 78(1):e45-e54. PubMed ID: 34173804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FGD5-AS1 accelerates intracerebral hemorrhage injury in mice by adsorbing miR-6838-5p to target VEGFA.
    Jiang F; Liu X; Wang X; Hu J; Chang S; Cui X
    Brain Res; 2022 Feb; 1776():147751. PubMed ID: 34902342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FGD5-AS1 potentiates autophagy-associated doxorubicin resistance by regulating the miR-154-5p/WNT5A axis in osteosarcoma.
    Fei D; Yuan H; Zhao M; Zhao D
    Cell Biol Int; 2022 Nov; 46(11):1937-1946. PubMed ID: 36041209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA TRHDE-AS1 inhibit the scar fibroblasts proliferation via miR-181a-5p/PTEN axis.
    Wei Y; Wang T; Zhang N; Ma Y; Shi S; Zhang R; Zheng X; Zhao L
    J Mol Histol; 2021 Apr; 52(2):419-426. PubMed ID: 33675502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.
    Shao S; Wang C; Wang S; Zhang H; Zhang Y
    Biomed Pharmacother; 2019 Sep; 117():109082. PubMed ID: 31212131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma.
    Zhang N; Shen H; Huang S; Wang F; Liu H; Xie F; Jiang L; Chen X
    Eur J Histochem; 2021 Nov; 65(4):. PubMed ID: 34783233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA FGD5 antisense RNA 1 targets Baculovirus inhibitor 5 via microRNA-497-5p to alleviate calcific aortic valve disease.
    Wei J; Zhu X; Sun A; Yan X; Meng X; Ge S
    Clin Hemorheol Microcirc; 2024; 86(3):285-302. PubMed ID: 37355887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA FGD5-AS1 Promotes Abdominal Aortic Aneurysm Growth Through the Activation of MMP3 in Vascular Smooth Muscle Cells.
    Xu Z; Lang D; Wang D; Hu S; Yang L
    Int Heart J; 2023 May; 64(3):470-482. PubMed ID: 37197924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
    Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
    In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA FGD5-AS1 Regulates Bone Marrow Stem Cell Proliferation and Apoptosis by Affecting miR-296-5p/STAT3 Axis in Steroid-Induced Osteonecrosis of the Femoral Head.
    Wu Y; Fang L; Gao Y; Zhao Z; Zhou L; Zhang G
    J Healthc Eng; 2022; 2022():9364467. PubMed ID: 35190765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FGD5-AS1 Alleviates Inflammation in Allergic Rhinitis through the miR-223-3p/COX11 Axis.
    Li B; Yu X; Pang F
    Int Arch Allergy Immunol; 2024; 185(3):201-211. PubMed ID: 38071964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.